SCOPUS 정보 검색 플랫폼

Volumn 151, Issue 4, 2000, Pages 260-267

Non-nucleosidic reverse transcriptase inhibitors;Inhibiteurs non nucleosidiques de la transcriptase inverse

Author keywords

NNRTI; Non nucleoside reverse transcriptase inhibitor

Indexed keywords

3 ETHYL 6 FLUORO 4 ISOPROPOXYCARBONYL 3,4 DIHYDRO QUINOXALIN 2(1H) ONE; CAPRAVIRINE; CD4 ANTIGEN; CYTOCHROME P450; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; EMIVIRINE; INDINAVIR; NELFINAVIR; NEVIRAPINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; UNCLASSIFIED DRUG; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; CLINICAL TRIAL; DRUG DISPOSITION; DRUG MECHANISM; DRUG METABOLISM; DRUG RESISTANCE; DRUG TOLERANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MUTATION; PHENOTYPE; RASH; VERTIGO; VIRUS REPLICATION; ANTIBIOTIC RESISTANCE; CHEMICALLY INDUCED DISORDER; CLASSIFICATION; DIZZINESS; DRUG ANTAGONISM; DRUG COMBINATION; DRUG EFFECT; DRUG ERUPTION; METABOLISM; REVIEW; TREATMENT OUTCOME;

ANTI-HIV AGENTS; DIZZINESS; DRUG ERUPTIONS; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; REVERSE TRANSCRIPTASE INHIBITORS; TREATMENT OUTCOME; VIRUS REPLICATION;

EID: 0033844830 PISSN: 0003410X EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (18)

References (64)

1
- 0029877789
- Non-nucleoside reverse transcriptase inhibitors for the treatment of human immunodeficiency virus type I (HIV-1) infections: Strategies to overcome drug resistance development
- (1996) Medicinal Research Reviews , vol.16 , pp. 125-157
- De Ciercq, E.¹

2
- 0029761518
- Nevirapine: A review of its development, pharmacological profile and potential for clinical use
- (1996) Exp Opin Invest Drugs , vol.5 , pp. 1183-1199
- Murphy, R.L.¹ Montaner, J.²

3
- 0008159553
- Once daily dosing of nevirapine: A retrospective, cross-study analysis. 12(th) World AIDS Conference, Geneva, Switzerland, 1998
- Dusek, A.¹ Hall, D.² Lamson, M.³ Myers, M.⁴

4
- 0008199217
- Antiviral efficacy of twice daily Rescriptor® (delavirdine mesylate) plus nelfinavir, didanosine and stavudine in an open-label randomized study of triple and quadruple treatment regimens in HIV-1 infected individuals. 4(th) International Congress on Drug Therapy in HIV Infection, Glasgow, UK
- (1998) , pp. 78
- Wathen, L.K.¹ Freimuth, W.W.² Cox, S.R.³ Getchel, L.D.⁴ Paxton, L.M.⁵ Huang, D.C.⁶

5
- 0008203188
- Delavirdine and marketed protease inhibitors: Pharmacokinetic interaction studies in healthy volunteers. 4(th) Conference on Retroviruses and Opportunistic Infections. Washington, DC
- (1997) , pp. 372
- Cox, S.R.¹ Ferry, J.J.² Batts, D.H.³

6
- 0008202191
- Delavirdine and nelfinavir: A pharmacokinetic drug-drug interaction in healthy volunteers. 5(th) Conference on Retroviruses and Opportunistic Infections, Chicago, Ill
- (1998) , pp. 345
- Cox, S.R.¹ Schneck, D.W.² Herman, B.D.³

7
- 0028900894
- Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus
- (1995) J Acquir Immune Defic Syndr , vol.8 , pp. 141-151
- Cheeseman, S.H.¹ Havlir, D.² Mc Laughlin, M.³

8
- 8944232862
- Randomized, controlled phase I/II trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients
- (1996) Antimicrob Agents Chemother , vol.40 , pp. 1657-1664
- Davey, R.T.¹ Chaitt, D.G.² Reed, G.F.³

9
- 0028930117
- High-dose nevirapine: Safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection
- (1995) J Infect Dis , vol.171 , pp. 537-545
- Havlir, D.¹ Cheeseman, S.H.² Mc Laughin, M.³

10
- 16944364799
- High-dose nevirapine in previously untreated human immunodeficiency virus type-1-infected persons does not result in sustained suppression of viral replication
- (1997) J Infect Dis , vol.175 , pp. 966-970
- De Jong, M.D.¹ Vella, S.² Carr, A.³

11
- 0029896976
- A controlled trial of nevirapine plus zidovudine versus zidovudine alone in p24 antigenaemic HIV-infected patients
- (1996) AIDS , vol.10-12 , pp. 635-641
- Carr, A.¹ Vella, S.² De Jong, M.³

12
- 0008203190
- Tolerance and efficacy of delavirdine mesylate (DLV) and zidovudine (ZDV) therapy in the treatment of HIV infected patients (study M/3331/013B). 4(th) International Congress on Drug Therapy in HIV Infection, Glasgow, UK
- (1998) , pp. 92
- Joly, V.¹

13
- 0008241887
- Delavirdine (DLV) combined with zidovudine (ZDV) or didanosine (ddI) produces sustained reduction in viral burden and increases in CD4 count in early and advanced HIV-1 infection. XI International Conference on AIDS, Vancouver
- (1998) , pp. 295
- Freimuth, W.W.¹ Chuang-Stein, C.J.² Greenwald, C.A.³

14
- 0008242658
- A randomized, double-blind, placebo-controlled study comparing combination nucleoside and triple therapy for the treatment of advanced HIV disease. 4(th) Conference on Retroviruses and Opportunistic Infections. Washington, DC
- (1997)
- Henry, K.¹ Tiemy, C.² Kahn, J.³

15
- 0030317268
- Nevirapine, zidovudine and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial
- (1996) Ann Intern Med , vol.124 , pp. 1019-1030
- D'Aquila, R.T.¹ Hughes, M.D.² Johnson, V.A.³

16
- 0032565098
- A randomized, double-blind trial comparing combinations of inevirapne, didanosine and zidovudine for HIV-infected patients. The INCAS trial
- (1998) JAMA , vol.279 , pp. 930-937
- Montaner, J.S.¹ Reiss, P.² Cooper, D.³

17
- 0008196535
- Sustained plasma viral burden reductions and CD4 increases in HIV-1 infected patients with Rescriptor plus Retrovir plus Epivir. 5(th) Conference on Retroviruses and Opportunistic Infections, Chicago, Ill
- (1998) , pp. 699
- Sargent, S.¹ Green, S.² Para, M.³

18
- 0008203191
- Second placebo-controlled study in naive individuals confirms the role of delavirdine in higly active antiretroviral, proteae-sparing treatment. 6(th) Conference on Retroviruses and Opportunistic Infections, 1999, Chicago, IL
- Wood, R.¹ Emini, D.A.² Moyle, G.³ De Cian, W.⁴ Ingrosso, A.⁵ Greenwald, C.⁶

19
- 0008161129
- The Atlantic study: A randomised open-label study comparing two protease inhibitors (PI)-sparing antiretroviral strategies versus a standard PI-containing regimen. 6(th) Conference on Retro-viruses and Opportunistic Infections, 1999, Chicago, IL
- Katlama, C.¹ Murphy, R.² Johnson, V.³

20
- 0008241888
- A double-blind, placebo-controlled study to assess the safety, tolerability and antiretroviral activity of efavirenz in combination with open-label zidovudine and lamivudine in HIV-1 infected patients [DMP 266-004]. 12(th) World AIDS Conference, Geneva, June 28-July 3, 1998
- Mayers, D.¹ Jemesk, J.² Eyster, E.³

21
- 0008162016
- A Phase III, Multicenter, randomized, open-Label study to compare the antiretroviral activity and tolerability of efavirenz (EFV) +indinavir (IDV), versus EFV + zidovudine (ZDV) +lamivudine (3TC), versus IDV + ZDV + 3TC at 48 Weeks (Study DMP 266-006). 6(th) Conference on Retroviruses and Opportunistic Infections, 1999, Chicago, IL
- Tashima, K.¹ Staszewski, S.² Stryker, R.³

22
- 0008238642
- Efficacy of Efavirenz (SUSTIVA®) Containing regimens in patients with baseline plasma HIV-RNA viral loads exceeding 100,000 copies/mL. 6(th) Conference on Retroviruses and Opportunistic Infections, 1999, Chicago, IL
- Manion, D.J.¹ Labriola, D.F.² Ruiz, N.M.³

23
- 0031800832
- A pilot study of nevirapine, indinavir and lamivudine among patients with advanced human immunodeficiency virus disease who have had failure of combination nucleoside therapy
- (1998) J Infect Dis , vol.177 , pp. 1514-1520
- Harris, M.¹ Durakovic, C.² Rae, S.³

24
- 0008160128
- Stavudine (d4T), nelfinavir (NFV) and nevirapine (NVP): Suppression of HIV-1 RNA to fewer than 50 copies/ml during 5 months of therapy. 12(th) World AIDS Conference, Geneva, Switzerland
- (1998) , pp. 12275
- Skowron, G.¹ Leoung, G.² Berman, B.Y.L.³

25
- 0008237510
- Virologic efficacy of nelfinavir (NFV) and/or efavirenz (EFZ) in combination with new nucleoside analogs in nucleoside experienced subjects. 6(th) Conference on Retroviruses and Opportunistic Infections, 1999, Chicago, IL
- Albrecht, M.¹ Katzenstein, D.² Bosch, R.³ Liou, S.⁴ Hammer, S.⁵

26
- 0008199979
- Effect of nelfinavir/indinavir/delavirdine in HIV + patients with extensive antiviral experience. 12(th) World AIDS Conference, Geneva, Switzerland
- (1998) , pp. 12329
- Lyle, G.¹

27
- 0032581593
- Clinical experience with adding delavirdine to combination therapy in patients in whom multiple anti-retroviral treatment including protease inhibitors has failed
- (1998) AIDS , vol.12 , pp. 1333-1340
- Bellman, P.C.¹

28
- 0008199218
- Sustained viral suppression with delavirdine and indinavir combination therapies. 6(th) Conference on Retroviruses and Opportunistic Infections, 1999, Chicago, IL
- Eron, J.¹ Walmsley, S.² Wathen, L.³

29
- 0008267133
- Efficacy of the combination stavudine, didanosine and nevirapine as initial antiretroviral therapy and following treatment with HIV-1 protease inhibitors - 26 week data. 12(th) World AIDS Conference, Geneva, Switzerland
- (1998) , pp. 22357
- Pell, C.M.¹ Bodsworth, N.J.² Donovan, B.³

30
- 0008160827
- Safety and pharmacokinetics of nevirapine in neonates born to HIV-1 infected women: 4(th) Conference on Retroviruses and Opportunistic Infections, Washington DC
- (1997) , pp. 723
- Mirochnik, M.¹ Sullivan, J.² Gagnier, P.³ Fenton, T.⁴ Sperling, R.⁵

31
- 0008196057
- Anti-retroviral use in pregnancy in PACTG 316; a phase III randomized, blinded study of single-dose intrapartum/ neonatal nevirapine to reduce mother to infant HIV transmission. 12(th) World AIDS Conference, Geneva, Switzerland
- (1998) , pp. 23281
- Dorenbum-Kracer, A.¹ Sullivan, J.² Gelber, R.³

32
- 0008202194
- Cutaneous eruptions associated with nevirapine therapy in HIV-1 infected individuals. XI International Conference on AIDS, Vancouver
- (1996) , pp. 1202
- Kohlbrenner, V.¹ Dransfield, K.² Cotton, D.³ Robinson, P.⁴ Myers, M.⁵

33
- 0032554284
- Nevirapine-associated Stevens-Johnson syndrome
- (1998) Lancet , vol.351 , pp. 567
- Warren, K.J.¹ Boxwell, D.E.² Kim, N.Y.³ Drolet, B.⁴

34
- 0032507306
- Nevirapine and rashes
- (1998) Lancet , vol.351 , pp. 1133
- Barner, A.¹ Myers, M.²

35
- 0027957791
- Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
- (1994) J Virol , vol.68 , pp. 1660-1666
- Richman, D.D.¹ Havlir, D.² Corbeil, J.³

36
- 0026318387
- Human immuno-deficiency virus type I mutants resistant to nonucleoside inhibitors of reverse transcriptase arise in tissue culture
- (1991) Proc Natl Acad Sci USA , vol.88 , pp. 11241-11245
- Richman, D.D.¹ Shih, C.-K.² Lowy, I.³

37
- 0008158807
- Delavirdine (DLV) susceptibility of HIV-1 isolates obtained from patients receiving DLV monotherapy. 3(rd) Conference on Retroviruses and Opportunistic Infections, 1996, Washington DC
- Demeter, L.¹ Shafer, R.² Para, M.³

38
- 0027231438
- A mutation in reverse transcriptase of bis (heteroaryl) piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonucleoside inhibitors
- (1993) Proc Natl Acad Sci USA , vol.90 , pp. 4713-4717
- Dueweke, T.J.¹ Pushkarskays, T.² Poppe, S.M.³

39
- 0031052425
- HIV-1 drug susceptibilities and reverse transcriptase mutations in patients receiving combination therapy with didanosine and delavirdine
- (1997) J AIDS , vol.14 , pp. 136-144
- Demeter, L.M.¹ Meehan, P.M.² Morse, G.³

40
- 0008240597
- Virological resistance to efavirenz. 12(th) World AIDS Conference, Geneva, Switzerland
- (1998) , pp. 41213
- Bacheler, L.¹ Weislow, O.² Snyder, S.³ Hanna, G.⁴ D'Aquila, R.⁵

41
- 0028785708
- L-743,726 (DMP 266): A novel, highly potent non-nucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase
- (1995) Antimicrob Agents Chemother , vol.39 , pp. 2602-2605
- Young, S.D.¹ Britcher, S.F.² Tran, L.O.³

42
- 0008238643
- Preliminary efficacy and safety of repeated multiple doses of MKC-442 in HIV-infected volunteers. 4(th) Conference on Retroviruses and Opportunistic Infections, Washington, DC
- (1997) , pp. 1
- Moxham, C.P.¹ Borroto-Esoda, K.² Noel, D.³ Furman, P.A.⁴ Szczech, G.M.⁵ Barry, D.W.⁶

43
- 0008196537
- GW420867X, a new non-nucleoside reverse transcriptase inhibitor, single and repeat dose pharmacokinetics (PK). 6(th) Conference on Retroviruses and Opportunistic Infections, 1999, Chicago, IL
- Moore, K.¹ Cass, L.² Kapoor, A.³

44
- 0008198289
- A second generation non-nucleoside reverse transciptase inhibitor (S-1153) for the treatment of HIV infection: A phase I study. 12(th) World AIDS Conference, Geneva, Switzerland
- (1998) , pp. 12214
- Dezube, B.J.¹ Jacobs, M.S.G.² Leoung, G.³

45
- 0008196058
- DMP 961 and DMP 963: 2nd Generation Non-Nucleoside Reverse Transcriptase Inhibitors Active Against The RT K103N Mutant. 6(th) Conference on Retroviruses and Opportunistic Infections, 1999, Chicago, IL
- Erickson-Viitanen, S.¹ Corbett, J.² Ko, S.S.³

46
- 0007010412
- Antire-troviral therapy for HIV infection in 1998. Updated recommendations of the International AIDS Society - USA panel
- (1998) JAMA , vol.280 , pp. 78-86
- Carpenter, C.C.J.¹ Fischl, M.A.² Hammer, S.M.³

47
- 0008203193
- STRATEGIES d'utilisation des antiretroviraux dans l'infection par le VIH. Rapport 1998. Paris, Medecine-Sciences Flammarion
- Dormont, J.¹

48
- 0008238644
- Durability of antiviral activity of efavirenz in combination with indinavir [DMP 266-003, Cohort IV]. 38(th) Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, CA
- (1998) , pp. 104
- Havlir, D.¹ Hicks, C.² Kahn, J.³

49
- 0032554528
- Abnormal fat accumulation in patients with HIV-1 infection
- (1998) Lancet , vol.351 , pp. 867-870
- Lipsky, J.¹

50
- 0032554552
- Visceral abdominal-fat accumulation associated with use of indinavir
- (1998) Lancet , vol.351 , pp. 871-875
- Miller, K.D.¹ Jones, E.² Yanovski, J.A.³ Shankar, R.⁴ Feuerstein, I.⁵ Falloon, J.⁶

51
- 0032493043
- A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV protease inhibitors
- (1998) AIDS , vol.12
- Carr, A.¹ Samaras, K.² Burton, S.³

52
- 0008241892
- Abnormal fat distribution in AIDS patients following protease inhibitors therapy: FDA summary. 5(th) Conference on Retroviruses and Opportunistic Infections, Chicago, Ill
- (1998) , pp. 412
- Mann, M.¹ Piazza-Hepp, T.² Koller, E.³ Gibert, C.⁴

53
- 0008160657
- Evidence of unique metabolic effects of protease inhibitors. 5(th) Conference on Retroviruses and Opportunistic Infections, Chicago, Ill
- (1998) , pp. 414
- Mulligan, K.¹ Tai, V.W.² Algren, H.³ Chernoff, D.N.⁴ Lo, J.C.⁵ Schambelan, M.⁶

54
- 0008235162
- Diabetes and hyperglycemia in patients receiving protease inhibitors. 5(th) Conference on Retroviruses and Opportunistic Infections, Chicago, Ill
- (1998) , pp. 415
- Keruly, J.C.¹ Chaisson, R.E.² Moore, R.D.³

55
- 0032903844
- Reversion of metabolic abnormalities after switching from HIV-1 protase inhbitors to nevirapine
- (1999) AIDS , vol.13 , pp. 805-810
- Martinez, E.¹ Conget, I.² Lozano, L.³ Casamitjana, R.⁴ Gatell, J.⁵

56
- 0008275847
- Prophylaxis against HIV-1 infection in chimpanzees by nevirapine. 4(th) Conference on Retroviruses and Opportunistic Infections, Washington DC
- (1997) , pp. 614
- Grob, P.M.¹ Cao, Y.² Muchmore, E.³

57
- 0008235163
- Ritonavir pharmacokinetics during combination therapy with delavirdine. 5(th) Conference on Retroviruses and Opportunistic Infections, Chicago, Ill
- (1998) , pp. 343
- Morse, G.D.¹ Shelton, M.J.² Hewitt, R.G.³

58
- 0008162020
- Effect of nevirapine on pharmacokinetics of indinavir and ritonavir in HIV-1 patients. 4(th) Conference on Retroviroses and Opportunistic Infections, Washington DC
- (1997) , pp. 374
- Murphy, R.¹ Gagnier, P.² Lamson, M.³ Dusek, A.⁴ Ju, W.⁵ Hsu, A.⁶

59
- 0008241893
- Saquinavir soft gel capsule (Fortovase) pharmacokinetics and drug interactions: 5(th) Conference on Retroviruses and Opportunistic Infections, Chicago, Ill
- (1998) , pp. 354
- Buss, N.¹

60
- 0008196539
- Drug interaction study between saquinavir and nevirapine. 4(th) Conference on Retroviruses and Opportunistic Infections, Washington DC
- (1997) , pp. 614
- Sahai, J.¹ Cameron, W.² Salgo, M.³

61
- 0008201532
- Stavudine, nelfinavir and nevirapine: Preliminary safety, activity and pharmacokinetic interactions. 5(th) Conference on Retroviruses and Opportunistic Infections, Chicago, Ill
- (1998) , pp. 350
- Skowron, G.¹ Leoung, G.² Dusek, A.³

62
- 0008159558
- The pharmacokinetics of nelfinavir alone and in combination with nevirapine. 5TH Conference on Retroviruses and OpportuniStiC Infections, Chicago, Ill
- (1998) , pp. 351
- Merry, C.¹ Barry, M.G.² Mulcahy, F.N.³ Ryan, M.⁴ Back, D.⁵

63
- 0008275848
- Pharmacokinetics of efavirenz and ritonavir after multiple oral doses in healthy volunteers. 12(th) World AIDS Conference, Geneva, Switzerland
- (1998) , pp. 42269
- Fiske, W.D.¹ Benedek, I.H.² Joseph, J.L.³

64
- 0008239709
- Pharmacokinetic interaction between efavirenz and nelfinavir mesylate in healthy volunteers. 5(th) Conference on Retroviruses and Opportunistic Infections, Chicago, Ill
- (1998) , pp. 349
- Fiske, W.D.¹ Benedek, L.H.² White, S.J.³ Pepperess, K.A.⁴ Joseph, J.L.⁵ Kornhauser, D.M.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.